Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
A randomized, multinational, double-blind, placebo-controlled, parallel-group design pilot study to estimate the tolerability, safety, pharmacokinetics, and pharmacodynamic effects of teriflunomide for 24 weeks when added to treatment with glatiramer acetate in subjects with multiple sclerosis https://www.kusajili.fr:443/Trial/PyUgGOqlVkKL7Jr5eL3_1w%24a-randomized-multinational-double-blind-placebo-controlled-parallel-group-design-pilot-study-to-estimate-the-tolerability-safet
I have read and accept the terms of use of the site and the Privacy Policy
Send your message